544642

- Allotment of 3,13,521 Equity Shares under Wakefit Employee Stock Option Plan - 2019 (ESOP 2019) on August 27, 2026, due to exercise of vested options. - Paid-up equity capital increased from 33,13,31,698 to 33,16,45,219 Equity Shares.

- Intimation of Schedule of Analyst / Institutional Investor Meeting - Concall Date: August 27, 2026 - Concall Time: 03:00 PM onwards - Meeting Mode: Virtual Group Meeting

- Q1 FY27 saw encouraging momentum with revenue growing 16.6% YoY to ₹404.9 Cr, EBITDA up 25.2% YoY to ₹56 Cr (13.9% margin), and PAT up 19.2% YoY to ₹23.3 Cr. - Mattress category demonstrated strong 27.3% YoY growth. - The company is on track to add approximately 80 new COCO stores in FY27, after adding 27 in Q1, expanding its network to 165 stores across 100 cities. - Furniture category growth is expected to rebound to mid-to-late teens over the next two quarters, with a significant 25-30% step-jump when Jumbo stores open (first one targeted for mid-2027 in Bangalore). - Capital expenditure for FY27 is projected at ₹100-120 Cr, with around 80% allocated to expanding the retail footprint, including the Jumbo store format. - The full impact of raw material price increases is expected to reflect in H1 FY27, with H1 contribution margin potentially 100-120 bps lower than Q1, assuming stable raw material prices. No further price hikes are anticipated barring unforeseen events. - A&P spends are projected to remain in the 7-8% range of revenue for FY27. - The long-term goal is to increase market share in the organized mattress market by 4-5 percentage points over the next 3-5 years through balanced growth and omni-channel expansion.

- Audio recording of the earnings conference call held on August 07, 2026, to discuss Q1 FY27 unaudited financial results, is available on the company website.

- Revenue from Operations ₹4,049.1mn vs ₹3,471.2mn (▲16.6% YoY) - Reported EBITDA (excl. Other Income) ₹564.0mn vs ₹450.4mn (▲25.2% YoY) - PAT ₹233.8mn vs ₹196.2mn (▲19.2% YoY) - EBITDA Margin 13.9% vs 13.0% (▲90bps)

- Consolidated Revenue ₹404.91 Cr vs ₹347.12 Cr (▲16.6% YoY) - EBITDA ₹56.40 Cr vs ₹45.04 Cr (▲25.2% YoY) - PAT ₹23.38 Cr vs ₹19.62 Cr (▲19.2% YoY) - EBITDA Margin 13.9% vs 13.0% (▲90bps)

- Consolidated Revenue ₹404.91Cr vs ₹347.12Cr (▲16.63% YoY) - EBITDA ₹72.02Cr vs ₹52.76Cr (▲36.50% YoY) - PAT ₹23.38Cr vs ₹19.62Cr (▲19.19% YoY) - EBITDA Margin 17.78% vs 15.20% (▲258bps)

- Consolidated Revenue ₹404.91Cr vs ₹347.12Cr (▲17% YoY) - EBITDA ₹72.02Cr vs ₹52.76Cr (▲37% YoY) - PAT ₹23.38Cr vs ₹19.62Cr (▲19% YoY) - EBITDA Margin 17.8% vs 15.2% (▲260bps)

- Concall Schedule for 1QFY27 Results - Concall Date: August 07, 2026 - Concall Time: 10:30 AM IST

- Board Meeting on August 06, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026. - Trading window closed from July 01, 2026, reopening 48 hours after the results announcement.

- Wakefit Innovations received a query from BSE regarding a significant increase in share volume. - The company clarified that there is no material information or event affecting operations/performance. - The volatility in share volume is completely market-driven.

- Wakefit Innovations Limited's NRC approved the grant of 4,57,611 Employee Stock Options under the WAKEFIT ESOP-2019 on July 13, 2026. - Each option has an exercise price of Re. 1/- and will vest between 12 months and 5 years from the grant date.

- Trading window closure for designated persons and their immediate relatives from July 01, 2026. - This is ahead of the un-audited financial results for the quarter ended June 30, 2026. - The window will re-open 48 hours post results announcement. - Board Meeting date for results will be intimated later.

- Mirae Asset Mutual Fund acquired 1,875,417 shares (0.57% stake) of Wakefit Innovations Ltd. via open market. - The acquisition, made on June 05, 2026, increased their total shareholding from 4.83% to 5.40%.

- Members of Wakefit Innovations Limited approved the alteration of its Memorandum of Association (MOA) on June 6, 2026. This expands the company's object clauses to include new business areas like chemicals, fertilizers, building materials, and broader home improvement and textile products.

- Shareholders approved the alteration of the Memorandum of Association (MOA) by amending existing object clauses and including new ones via remote e-voting. - The special resolution was passed with an overwhelming majority of 99.9994% votes in favor. - The e-voting period was from May 8, 2026, to June 6, 2026.

Management guided for an aspiration of at least 20% revenue growth for FY27 and plans to add over 80 net COCO store additions. Capex for FY27 is projected at INR120-140 crores, mainly for retail expansion including initial spending on a Jumbo store (first Jumbo store expected in early FY28). ESOP expenses are anticipated to decrease to INR12 crores for FY27. Management indicated that higher input costs and price pass-throughs might constrain margin expansion in the near term, potentially impacting EBITDA margins by 1-2 percentage points if aggressive growth targets are pursued, although no material margin dilution is expected for Q1 FY27. The company is observing positive growth trends in April, driven by its mattress portfolio, expanding furniture and furnishing reach, and entering adjacent categories, while prioritizing market share and customer lifetime value.

On May 26, 2026, Wakefit Innovations Limited allotted 13,64,949 fully paid-up Equity Shares of ₹1/- each to eligible employees/ESOP holders under the Wakefit ESOP-2019 scheme. This allotment increased the company's paid-up equity share capital from ₹32,99,66,749 to ₹33,13,31,698.

Wakefit Innovations Limited's Nomination and Remuneration Committee (NRC) approved the grant of 3,28,342 Employee Stock Options under the WAKEFIT ESOP-2019 on May 23, 2026. The options have an exercise price of Re. 1/- per option, will vest after a minimum of 12 months from the grant date, and are exercisable within one year of vesting.

Wakefit Innovations Limited announced that the audio recording of its Earnings conference call, held on May 22, 2026, is available on the company's website. The call discussed the audited financial results for the quarter and financial year ended March 31, 2026.

Wakefit Innovations reported strong Q4FY26 results. Consolidated Revenue from Operations was ₹343.6 Cr vs ₹302.6 Cr (▲13.5% YoY), Reported EBITDA (excl. Other Income) was ₹36.5 Cr vs ₹6.0 Cr (▲511.1% YoY), and Profit After Tax (PAT) was ₹121.8 Cr vs ₹-26.2 Cr (turned profitable YoY). EBITDA Margin expanded significantly to 10.6% vs 2.0% (▲860bps). Management guided for revenue growth in FY27, driven by mattress portfolio strength and expansion in furniture/furnishings.

Wakefit Innovations Limited's Board of Directors, at its meeting on May 21, 2026, approved the appointment of M/s BMP & Co. LLP as the Secretarial Auditors for a period of five consecutive years, commencing from FY 2026-27 till FY 2030-2031. The appointment is subject to approval by shareholders at the ensuing Annual General Meeting.

Consolidated Revenue ₹3,436.00Mn vs ₹3,026.05Mn (▲13.54% YoY), EBITDA ₹538.52Mn vs ₹144.29Mn (▲273.23% YoY), PAT of ₹1,217.45Mn compared to a loss of ₹261.95Mn in the prior year. EBITDA Margin expanded to 15.67% from 4.77% (▲1090bps). The board also approved the appointment of M/s BMP & Co. LLP as Secretarial Auditors for five years.

Consolidated Revenue ₹343.60 Cr vs ₹302.61 Cr (▲13.55% YoY), EBITDA ₹53.85 Cr vs ₹14.43 Cr (▲273.22% YoY), PAT ₹121.75 Cr vs (₹26.20 Cr) (▲564.62% YoY, swung from loss to profit). EBITDA Margin 15.67% vs 4.77% (▲1090bps). The board also approved the appointment of M/s BMP & Co. LLP as Secretarial Auditors for five years.